Selangor, Malaysia - Garlic extract may be an effective weapon against multi-drug resistant strains of pathogenic bacteria associated with urinary tract infections (UTI), according to a recent study published in the Pertanika Journal of Tropical Agricultural Science.
Conducted by researchers at the Birla Institute of Technology and Sciences in India, the study found that "even crude extracts of [garlic] showed good activity against multidrug resistant strains where antibiotic therapy had limited or no effect. This provides hope for developing alternative drugs which may be of help in fighting the menace of growing antibacterial resistance," the team states.
Urinary tract infection is the second most common infectious disease encountered in community practice. Worldwide, about 150 million people are diagnosed each year with UTI, at a total treatment cost in the billions of dollars. Although UTI is usually treated with antibiotics, "emerging antimicrobial resistance compels us to look back into traditional medicines or herbal products, which may provide appropriate/acceptable alternative solutions," the authors argue.
Garlic (Allium sativum) has been traditionally used for the treatment of diseases since ancient times. A wide range of microorganisms - including bacteria, fungi, protozoa and viruses - are known to be sensitive to garlic preparations. Allicin and other sulphur compounds are thought to be the major antimicrobial factors in garlic.
In this study, the team found that 56% of 166 bacteria strains isolated from the urine of people with UTI showed a high degree of resistance to antibiotics. However, about 82% of the antibiotic resistant bacteria were susceptible to a crude aqueous extract of Allium sativum. According to the researchers, "ours is the first study to report the antibacterial activity of aqueous garlic extract against multidrug resistant bacterial isolates from infected urine samples leading to UTI."
"To conclude, there is evidence that garlic has potential in the treatment of UTI and maybe other microbial infections," says the team. "However, it is necessary to determine the bioavailability, side effects and pharmacokinetic properties in more detail."
For further information please contact:
Department of Biological Sciences
Birla Institute of Technology and Sciences
Hyderabad Campus, Hyderabad, India
Email: email@example.com, firstname.lastname@example.org
Tel: +91 40 6630 3563; Mobile: +91 90 1020 2863
About Pertanika Journal of Tropical Agricultural Science (JTAS)
Pertanika Journal of Tropical Agricultural Science (JTAS) is published by Universiti Putra Malaysia in English and is open to authors around the world regardless of nationality. The journal is published four times a year in February, May, August and November. Other Pertanika series include Pertanika Journal of Science & Technology (JST), and Pertanika Journal of Social Sciences & Humanities (JSSH).
JTAS aims to provide a forum for high quality research related to tropical agricultural research. Areas relevant to the scope of the journal include: agricultural biotechnology, biochemistry, biology, ecology, fisheries, forestry, food sciences, entomology, genetics, microbiology, pathology and management, physiology, plant and animal sciences, production of plants and animals of economic importance, and veterinary medicine. The journal publishes original academic articles dealing with research on issues of worldwide relevance.
The papers are available from these links: http://bit.ly/1JPtk5v
For more information about the journal, contact:
The Chief Executive Editor (UPM Journals)
Head, Journal Division, UPM Press
Office of the Deputy Vice Chancellor (R&I)
IDEA Tower 2, UPM-MDTC Technology Centre
Universiti Putra Malaysia
43400 Serdang, Selangor
Phone: +603 8947 1622 | +6016 217 4050
Press release distributed by ResearchSEA for Pertanika Journal.